Singapore has a chance to shine in precision medicine
Existing research capabilities and support for new startups can drive growth in this field
IMAGINE if the medicine prescribed to you could be tailored to your genetic makeup. This would prevent instances of drugs having no effect – or worse, making you sicker.
With precision medicine, this is not merely a matter of imagination. Nalagenetics, a spin-off of the Agency for Science, Technology and Research (A*Star), aims to do just this.
The company is working with the National University Hospital and Raffles Medical Group on something called “pre-emptive pharmacogenomics”. This involves understanding a patient’s genomic profile and cross-checking it with biomarkers, to pre-emptively flag any issues with medication.
TRENDING NOW
Qatari LNG ship struck in Strait of Hormuz, testing US talks
DBS, OCBC and UOB shares hit all-time highs as sentiment improves
‘Baptism of fire’: Andre Khor on leading Singapore refiner Aster through an energy crisis
Singapore retains top spot as most expensive city for HNWIs, with five Apac cities in global top 10